文献速递围术期管理与 ERAS

术前COVID-19疫苗接种与大型血管手术后围术期死亡率降低相关

Preoperative COVID-19 Vaccination Is Associated with Decreased Perioperative Mortality After Major Vascular Surgery.
PubMed 文献 · Ann Surg · 2024-05-10

这项多中心回顾性研究纳入2021年12月至2023年8月期间接受大型血管手术的85,424例患者,其中19,161例(22.4%)未接种疫苗。校正危险因素后,疫苗接种与死亡率降低相关(OR 0.7,95%CI:0.62-0.81,P<0.0001),且在开放腹主动脉瘤修复、血管内动脉瘤修复、颈动脉支架置入和腹股沟下下肢旁路术后均观察到死亡率 odds 降低。

要点

  • 未接种疫苗患者较年轻(平均68.44±10.37岁 vs 72.11±9.20岁,P<0.001)且合并症更少。
  • 校正后疫苗接种与30天内或出院前全因死亡率降低相关(OR 0.7,95%CI:0.62-0.81,P<0.0001)。
  • 开放腹主动脉瘤修复、血管内动脉瘤修复、颈动脉支架置入和腹股沟下旁路术后接种者 mortality odds 均降低。

核心结论

  • COVID-19疫苗接种与血管手术患者围术期死亡率降低相关,该关联在主动脉瘤修复、颈动脉支架置入和腹股沟下旁路患者中最为明显。

研究设计与样本

  • 多中心回顾性研究,纳入2021年12月至2023年8月期间接受大型血管手术的患者共85,424例,其中19,161例(22.4%)未接种疫苗。

主要发现

  • 未接种疫苗患者较接种患者年轻(平均68.44±10.37岁 vs 72.11±9.20岁,P<0.001),且高血压、充血性心力衰竭、慢性阻塞性肺疾病和透析等合并症更少。
  • 校正危险因素后,疫苗接种与死亡率降低相关(OR 0.7,95%CI:0.62-0.81,P<0.0001)。
  • 按手术类型分层,接种患者开放腹主动脉瘤修复术后死亡 odds 降低(OR 0.6,95%CI:0.42-0.97,P=0.03)。
  • 接种患者血管内动脉瘤修复术后死亡 odds 降低(OR 0.6,95%CI:0.43-0.83,P=0.002)。
  • 接种患者颈动脉支架置入术后死亡 odds 降低(OR 0.7,95%CI:0.51-0.88,P=0.004),腹股沟下下肢旁路术后死亡 odds 亦降低(OR 0.7,95%CI:0.48-0.96,P=0.03)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of this study was to examine the effect of COVID-19 vaccination on perioperative outcomes after major vascular surgery. BACKGROUND: COVID-19 vaccination is associated with decreased mortality in patients undergoing various surgical procedures. However, the effect of vaccination on perioperative mortality after major vascular surgery is unknown. METHODS: This is a multicenter retrospective study of patients who underwent major vascular surgery between December 2021 and August 2023. The primary outcome was all-cause mortality within 30 days of index operation or before hospital discharge. Multivariable models were used to examine the association between vaccination status and the primary outcomes. RESULTS: Of the total 85,424 patients included, 19,161 (22.4%) were unvaccinated. Unvaccinated patients were younger compared with vaccinated patients (mean age 68.44 +/- 10.37 y vs 72.11 +/- 9.20 y, P <0.001) and less likely to have comorbid conditions, including hypertension, congestive heart failure, chronic obstructive pulmonary disease, and dialysis. After risk factor adjustment, vaccination was associated with decreased mortality (OR 0.7, 95% CI: 0.62-0.81, P <0.0001). Stratification by procedure type demonstrated that vaccinated patients had decreased odds of mortality after open abdominal aortic aneurysm (OR 0.6, 95% CI: 0.42-0.97, P =0.03), endovascular aneurysm repair (OR 0.6, 95% CI: 0.43-0.83, P= 0.002), carotid artery stenting (OR 0.7, 95% CI: 0.51-0.88, P =0.004) and infrainguinal lower extremity bypass (OR 0.7, 95% CI: 0.48-0.96, P =0.03). CONCLUSIONS: COVID-19 vaccination is associated with reduced perioperative mortality in patients undergoing vascular surgery. This association is most pronounced in patients undergoing aortic aneurysm repair, carotid stenting, and infrainguinal bypass.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Ratner M, Garg K, Chang H, et al. Preoperative COVID-19 Vaccination Is Associated with Decreased Perioperative Mortality After Major Vascular Surgery. Ann Surg. 2024. PMID: 38726660. doi:10.1097/SLA.0000000000006341

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。